Cyclosporine

Generic name: Pronounced as (sye' kloe spor een)
Brand names
  • Gengraf®
  • Neoral®
  • Sandimmune® Capsules
  • Sandimmune® Oral Solution
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 12/15/2015

Cyclosporine is available in its original form and as another product that has been modified (changed) so that the medication can be better absorbed in the body. Original cyclosporine and cyclosporine (modified) are absorbed by the body in different amounts, so they cannot be substituted for one another. Take only the type of cyclosporine that was prescribed by your doctor. When your doctor gives you a written prescription, check to be sure that he or she has specified the type of cyclosporine you should receive. Each time you have your prescription filled, look at the brand name printed on your prescription label to be sure that you have received the same type of cyclosporine. Talk to your pharmacist if the brand name is unfamiliar or you are not sure you have received the right type of cyclosporine.

Taking cyclosporine or cyclosporine (modified) may increase the risk that you will develop an infection or cancer, especially lymphoma (cancer of a part of the immune system) or skin cancer. This risk may be higher if you take cyclosporine or cyclosporine (modified) with other medications that decrease the functioning of the immune system such as azathioprine (Imuran), cancer chemotherapy, methotrexate (Rheumatrex), sirolimus (Rapamune), and tacrolimus (Prograf). Tell your doctor if you are taking any of these medications, and if you have or have ever had any type of cancer. To reduce your risk of skin cancer, plan to avoid unnecessary or prolonged exposure to sunlight and to wear protective clothing, sunglasses, and sunscreen during your treatment. If you experience any of the following symptoms, call your doctor immediately: sore throat, fever, chills, and other signs of infection; flu-like symptoms; coughing; difficulty urinating; pain when urinating; a red, raised, or swollen area on the skin; new sores or discoloration on the skin; lumps or masses anywhere in your body; night sweats; swollen glands in the neck, armpits, or groin; trouble breathing; chest pain; weakness or tiredness that does not go away; or pain, swelling, or fullness in the stomach.

Cyclosporine and cyclosporine (modified) may cause high blood pressure and kidney damage. Tell your doctor if you have or have ever had high blood pressure or kidney disease. Also tell your doctor if you are taking any of the following medications: amphotericin B (Amphotec, Fungizone); cimetidine (Tagamet); ciprofloxacin (Cipro); colchicine; fenofibrate (Antara, Lipophen, Tricor); gemfibrozil (Lopid); gentamicin; ketoconazole (Nizoral); melphalan (Alkeran); nonsteroidal anti-inflammatory drugs such as diclofenac (Cataflam, Voltaren), naproxen (Aleve, Naprosyn), and sulindac (Clinoril); ranitidine (Zantac); tobramycin (Tobi); trimethoprim with sulfamethoxazole (Bactrim, Septra); and vancomycin (Vancocin). If you experience any of the following symptoms, call your doctor immediately: dizziness; swelling of the arms, hands, feet, ankles, or lower legs; fast, shallow breathing; nausea; or irregular heartbeat.

If you have psoriasis, tell your doctor about all the psoriasis treatments and medications you are using or have used in the past. The risk that you will develop skin cancer is greater if you have ever been treated with PUVA (psoralen and UVA; treatment for psoriasis that combines an oral or topical medication with exposure to ultraviolet A light); methotrexate (Rheumatrex) or other medications that suppress the immune system; UVB (exposure to ultraviolet B light to treat psoriasis); coal tar; or radiation therapy. You should not be treated with PUVA, UVB, or medications that suppress the immune system while you are taking cyclosporine (modified) to treat psoriasis.

Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your body's response to cyclosporine or cyclosporine (modified).

Cyclosporine and cyclosporine (modified) are used with other medications to prevent transplant rejection (attack of the transplanted organ by the immune system of the person who received the organ) in people who have received kidney, liver, and heart transplants. Cyclosporine (modified) is also used alone or with methotrexate (Rheumatrex) to treat the symptoms of rheumatoid arthritis (arthritis caused by swelling of the lining of the joints) in patients whose symptoms were not relieved by methotrexate alone. Cyclosporine (modified) is also used to treat psoriasis (a skin disease in which red, scaly patches form on some areas of the body) in certain patients who have not been helped by other treatments. Cyclosporine and cyclosporine (modified) are in a class of medications called immunosuppressants. They work by decreasing the activity of the immune system.

Cyclosporine and cyclosporine (modified) both come as a capsule and a solution (liquid) to take by mouth. Cyclosporine is usually taken once a day. Cyclosporine (modified) is usually taken twice a day. It is important to take both types of cyclosporine on a regular schedule. Take cyclosporine or cyclosporine (modified) at the same time(s) each day, and allow the same amount of time between doses and meals every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take cyclosporine or cyclosporine (modified) exactly as directed. Do not take more or less of the medication or take it more often than prescribed by your doctor.

Your doctor will probably adjust your dose of cyclosporine or cyclosporine (modified) during your treatment. If you are taking either type of cyclosporine to prevent transplant rejection, your doctor will probably start you on a high dose of the medication and gradually decrease your dose. If you are taking cyclosporine (modified) to treat rheumatoid arthritis or psoriasis, your doctor will probably start you on a low dose of the medication and gradually increase your dose. Your doctor may also decrease your dose if you experience side effects of the medication. Tell your doctor how you are feeling during your treatment.

Cyclosporine (modified) helps control the symptoms of psoriasis and rheumatoid arthritis, but does not cure these conditions. If you are taking cyclosporine (modified) to treat psoriasis, it may take 2 weeks or longer for your symptoms to begin to improve, and 12 to 16 weeks for you to feel the full benefit of the medication. If you are taking cyclosporine (modified) to treat rheumatoid arthritis, it may take 4 to 8 weeks for your symptoms to improve. Continue to take cyclosporine (modified) even if you feel well. Do not stop taking cyclosporine (modified) without talking to your doctor. Your doctor may decrease your dose gradually.

You may notice an unusual smell when you open a blister card of cyclosporine capsules. This is normal and does not mean that the medication is damaged or unsafe to use.

Cyclosporine (modified) oral solution may gel or become lumpy if it is exposed to temperatures below 68 °F (20 °C). You can use the solution even if it has gelled, or you can turn the solution back to a liquid by allowing it to warm to room temperature (77 °F [25 °C]).

Cyclosporine and cyclosporine (modified) oral solution must be mixed with a liquid before use. Cyclosporine (modified) oral solution may be mixed with orange juice or apple juice but should not be mixed with milk. Cyclosporine oral solution may be mixed with milk, chocolate milk, or orange juice. You should choose one drink from the appropriate list and always mix your medication with that drink.

To take either type of oral solution, follow these steps:

  • Fill a glass (not plastic) cup with the drink you have chosen.

  • Remove the protective cover from the top of the dosing syringe that came with your medication.

  • Place the tip of the syringe into the bottle of solution and pull back on the plunger to fill the syringe with the amount of solution your doctor has prescribed.

  • Hold the syringe over the liquid in your glass and press down on the plunger to place the medication in the glass.

  • Stir the mixture well.

  • Drink all of the liquid in the glass right away.

  • Pour a little more of the drink you have chosen into the glass, swirl the glass around to rinse, and drink the liquid.

  • Dry the outside of the syringe with a clean towel and replace the protective cover. Do not wash the syringe with water. If you do need to wash the syringe, be sure that it is completely dry before you use it to measure another dose.

Cyclosporine and cyclosporine (modified) are also sometimes used to treat Crohn's disease (a condition in which the body attacks the lining of the digestive tract, causing pain, diarrhea, weight loss, and fever) and to prevent rejection in patients who have received pancreas or cornea transplants. Talk to your doctor about the possible risks of using this medication for your condition.

This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.

Before taking cyclosporine or cyclosporine (modified),

  • tell your doctor and pharmacist if you are allergic to cyclosporine, cyclosporine (modified), any other medications, or any of the inactive ingredients in cyclosporine or cyclosporine (modified) capsules or solution. Ask your pharmacist for a list of the inactive ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, and nutritional supplements you are taking, or plan to take. Be sure to mention the medications listed in the IMPORTANT WARNING section and any of the following: acyclovir (Zovirax); allopurinol (Zyloprim); amiodarone (Cordarone); angiotensin-converting enzyme (ACE) inhibitors such as benazepril (Lotensin), captopril (Capoten), enalapril (Vasotec), fosinopril (Monopril), lisinopril (Prinivil, Zestril), moexipril (Univasc), perindopril (Aceon), quinapril (Accupril), ramipril (Altace), and trandolapril (Mavik); angiotensin II receptor antagonists such as candesartan (Atacand), eprosartan (Teveten), irbesartan (Avapro), losartan (Cozaar), olmesartan (Benicar), telmisartan (Micardis), and valsartan (Diovan); certain antifungal medications such as fluconazole (Diflucan), and itraconazole (Sporanox); azithromycin (Zithromax); bromocriptine (Parlodel); calcium channel blockers such as diltiazem (Cardizem), nicardipine (Cardene), and verapamil (Calan); carbamazepine (Tegretol); cholesterol-lowering medications (statins) such as atorvastatin (Lipitor), fluvastatin (Lescol), lovastatin (Mevacor), pravastatin (Pravachol), and simvastatin (Zocor); clarithromycin (Biaxin); dalfopristin and quinupristin combination (Synercid); danazol; digoxin (Lanoxin); certain diuretics ('water pills') including amiloride (Midamor), spironolactone (Aldactone), and triamterene (Dyazide); erythromycin; HIV protease inhibitors such as indinavir (Crixivan), nelfinavir (Viracept), ritonavir (Norvir, in Kaletra), and saquinavir (Fortovase); imatinib (Gleevec); metoclopramide (Reglan); methylprednisolone (Medrol); nafcillin; octreotide (Sandostatin); oral contraceptives (birth control pills); orlistat (Xenical); phenobarbital; phenytoin (Dilantin); potassium supplements; prednisolone (Pediapred); repaglinide (Prandin); rifabutin (Mycobutin); rifampin (Rifadin, Rimactane); sulfinpyrazone (Anturane); terbinafine (Lamisil); and ticlopidine (Ticlid). Your doctor may need to change the doses of your medications or monitor you more carefully for side effects.

  • if you are taking sirolimus (Rapamune), take it 4 hours after you take cyclosporine or cyclosporine (modified).

  • tell your doctor what herbal products you are taking, especially St. John's wort.

  • tell your doctor if you have or have ever had any of the conditions mentioned in the IMPORTANT WARNING section or any of the following: low cholesterol, low levels of magnesium in your blood, any condition that makes it difficult for your body to absorb nutrients, or liver disease.

  • tell your doctor if you are pregnant or plan to become pregnant. If you become pregnant while taking either type of cyclosporine, call your doctor. Both types of cyclosporine may increase the risk that your baby will be born too early.

  • tell your doctor if you are breast-feeding or planning to breast-feed.

  • do not have vaccinations without talking to your doctor.

  • you should know that cyclosporine may cause growth of extra tissue in your gums. Be sure to brush your teeth carefully and see a dentist regularly during your treatment to decrease the risk that you will develop this side effect.

Avoid drinking grapefruit juice or eating grapefruit while taking cyclosporine or cyclosporine (modified).

Your doctor may tell you to limit the amount of potassium in your diet. Follow these instructions carefully. Talk to your doctor about the amount of potassium-rich foods such as bananas, prunes, raisins, and orange juice you may have in your diet. Many salt substitutes contain potassium, so talk to your doctor about using them during your treatment.

If you forget to take a dose, take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Cyclosporine and cyclosporine (modified) may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • headache

    • diarrhea

    • heartburn

    • gas

    • increased hair growth on the face, arms, or back

    • growth of extra tissue on the gums

    • acne

    • flushing

    • uncontrollable shaking of a part of your body

    • burning or tingling in the hands, arms, feet, or legs

    • muscle or joint pain

    • cramps

    • pain or pressure in the face

    • ear problems

    • breast enlargement in men

    • depression

    • difficulty falling asleep or staying asleep

  • Some side effects can be serious. If you experience any of the following symptoms, or those listed in the IMPORTANT WARNING section, call your doctor immediately:

    • unusual bleeding or bruising

    • pale skin

    • yellowing of the skin or eyes

    • seizures

    • loss of consciousness

    • changes in behavior or mood

    • difficulty controlling body movements

    • changes in vision

    • confusion

    • rash

    • purple blotches on the skin

    • swelling of the hands, arms, feet, ankles, or lower legs

  • Cyclosporine and cyclosporine (modified) may cause other side effects. Talk to your doctor if you experience unusual problems while taking either medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Do not store this medicine in the refrigerator and do not freeze it. Dispose of any remaining solution 2 months after you first open the bottle.

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include:

  • yellowing of the skin or eyes

  • swelling of the arms, hands, feet, ankles, or lower legs.

Do not let anyone else take your medicine. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The risk or severity of nephrotoxicity can be increased when Moxifloxacin is combined with Cyclosporine.
Repaglinide Repaglinide The serum concentration of Repaglinide can be increased when it is combined with Cyclosporine.
Montelukast Montelukast The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cyclosporine is combined with Montelukast.
Leflunomide Leflunomide Leflunomide may increase the immunosuppressive activities of Cyclosporine.
Delavirdine Delavirdine The metabolism of Cyclosporine can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Cyclosporine can be decreased when combined with Nevirapine.
Atorvastatin Atorvastatin The excretion of Atorvastatin can be decreased when combined with Cyclosporine.
Dolasetron Dolasetron The metabolism of Cyclosporine can be decreased when combined with Dolasetron.
Alendronate Alendronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cyclosporine is combined with Alendronic acid.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Cyclosporine.
Candesartan Candesartan The risk or severity of hyperkalemia can be increased when Candesartan is combined with Cyclosporine.
Cilostazol Cilostazol The metabolism of Cilostazol can be decreased when combined with Cyclosporine.
Clopidogrel Clopidogrel The metabolism of Cyclosporine can be decreased when combined with Clopidogrel.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The metabolism of Cyclosporine can be decreased when combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Cyclosporine may decrease the excretion rate of Conjugated estrogens which could result in a higher serum level.
Fenofibrate Fenofibrate The risk or severity of renal failure can be increased when Cyclosporine is combined with Fenofibrate.
Guanfacine Guanfacine Cyclosporine may decrease the excretion rate of Guanfacine which could result in a higher serum level.
Magnesium Gluconate Magnesium Gluconate The risk or severity of neuromuscular blockade can be increased when Cyclosporine is combined with Magnesium gluconate.
Magnesium Hydroxide Magnesium Hydroxide Cyclosporine may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Magnesium Oxide Magnesium Oxide The risk or severity of neuromuscular blockade can be increased when Cyclosporine is combined with Magnesium oxide.
Methylergonovine Methylergonovine The metabolism of Cyclosporine can be decreased when combined with Methylergometrine.
Mycophenolate Mycophenolate Mycophenolic acid may increase the immunosuppressive activities of Cyclosporine.
Nafarelin Nafarelin The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cyclosporine is combined with Nafarelin.
Naratriptan Naratriptan The risk or severity of hypertension can be increased when Cyclosporine is combined with Naratriptan.
Olsalazine Olsalazine The risk or severity of renal failure and hypertension can be increased when Olsalazine is combined with Cyclosporine.
Paregoric Paregoric The serum concentration of Cyclosporine can be increased when it is combined with Morphine.
Penbutolol Penbutolol The metabolism of Acebutolol can be decreased when combined with Cyclosporine.
Potassium Potassium Cyclosporine may decrease the excretion rate of Potassium cation which could result in a higher serum level.
Prednisone Prednisone Prednisone may increase the immunosuppressive activities of Cyclosporine.
Ranitidine Ranitidine Cyclosporine may decrease the excretion rate of Ranitidine which could result in a higher serum level.
Reserpine Reserpine The serum concentration of Cyclosporine can be increased when it is combined with Reserpine.
Rizatriptan Rizatriptan Cyclosporine may decrease the excretion rate of Rizatriptan which could result in a higher serum level.
Sumatriptan Sumatriptan The risk or severity of renal failure can be increased when Sumatriptan is combined with Cyclosporine.
Tacrolimus Tacrolimus Tacrolimus may increase the nephrotoxic activities of Cyclosporine.
Tiludronate Tiludronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cyclosporine is combined with Etidronic acid.
Tizanidine Tizanidine The therapeutic efficacy of Tizanidine can be decreased when used in combination with Cyclosporine.
Triamcinolone Triamcinolone Triamcinolone may increase the immunosuppressive activities of Cyclosporine.
Zolmitriptan Zolmitriptan The risk or severity of hypertension can be increased when Cyclosporine is combined with Zolmitriptan.
Ampicillin Injection Ampicillin Injection Cyclosporine may decrease the excretion rate of Ampicillin which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection The metabolism of Cyclosporine can be decreased when combined with Doxycycline.
Fluconazole Injection Fluconazole Injection The serum concentration of Cyclosporine can be increased when it is combined with Fluconazole.
Foscarnet Injection Foscarnet Injection Foscarnet may increase the nephrotoxic activities of Cyclosporine.
Hydromorphone Injection Hydromorphone Injection Cyclosporine may decrease the excretion rate of Hydromorphone which could result in a higher serum level.
Interferon Beta-1b Injection Interferon Beta-1b Injection Interferon beta-1b may increase the immunosuppressive activities of Cyclosporine.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection Interferon gamma-1b may increase the immunosuppressive activities of Cyclosporine.
Levofloxacin Injection Levofloxacin Injection The serum concentration of Cyclosporine can be increased when it is combined with Levofloxacin.
Meperidine Injection Meperidine Injection The metabolism of Meperidine can be decreased when combined with Cyclosporine.
Methylprednisolone Injection Methylprednisolone Injection The serum concentration of Methylprednisolone can be increased when it is combined with Cyclosporine.
Metoclopramide Injection Metoclopramide Injection Metoclopramide can cause an increase in the absorption of Cyclosporine resulting in an increased serum concentration and potentially a worsening of adverse effects.
Metronidazole Injection Metronidazole Injection The metabolism of Cyclosporine can be decreased when combined with Metronidazole.
Morphine Injection Morphine Injection The serum concentration of Cyclosporine can be increased when it is combined with Morphine.
Pamidronate Injection Pamidronate Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cyclosporine is combined with Pamidronic acid.
Vancomycin Injection Vancomycin Injection Cyclosporine may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Zidovudine Injection Zidovudine Injection Zidovudine may increase the immunosuppressive activities of Cyclosporine.
Altretamine Altretamine The metabolism of Amphetamine can be decreased when combined with Cyclosporine.
Cefuroxime Cefuroxime The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Cefuroxime.
Ondansetron Ondansetron The metabolism of Cyclosporine can be decreased when combined with Ondansetron.
Enoxaparin Injection Enoxaparin Injection The risk or severity of hyperkalemia can be increased when Cyclosporine is combined with Enoxaparin.
Torsemide Torsemide The risk or severity of renal failure can be increased when Cyclosporine is combined with Torasemide.
Olanzapine Olanzapine The metabolism of Olanzapine can be decreased when combined with Cyclosporine.
Dofetilide Dofetilide The metabolism of Dofetilide can be decreased when combined with Cyclosporine.
Eprosartan Eprosartan The risk or severity of hyperkalemia can be increased when Eprosartan is combined with Cyclosporine.
Hydroxychloroquine Hydroxychloroquine Hydroxychloroquine may increase the immunosuppressive activities of Cyclosporine.
Meloxicam Meloxicam The risk or severity of renal failure and hypertension can be increased when Meloxicam is combined with Cyclosporine.
Orlistat Orlistat Orlistat can cause a decrease in the absorption of Cyclosporine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Oxcarbazepine Oxcarbazepine The metabolism of Cyclosporine can be increased when combined with Oxcarbazepine.
Pantoprazole Pantoprazole Cyclosporine may decrease the excretion rate of Pantoprazole which could result in a higher serum level.
Risedronate Risedronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cyclosporine is combined with Risedronic acid.
Sevelamer Sevelamer The serum concentration of Cyclosporine can be decreased when it is combined with Sevelamer.
Telmisartan Telmisartan The risk or severity of hyperkalemia can be increased when Telmisartan is combined with Cyclosporine.
Temozolomide Temozolomide Temozolomide may increase the immunosuppressive activities of Cyclosporine.
Zaleplon Zaleplon The metabolism of Cyclosporine can be decreased when combined with Zaleplon.
Anakinra Anakinra Anakinra may increase the immunosuppressive activities of Cyclosporine.
Linezolid Linezolid Linezolid may increase the immunosuppressive activities of Cyclosporine.
Trimipramine Trimipramine The metabolism of Trimipramine can be decreased when combined with Cyclosporine.
Etanercept Injection Etanercept Injection Etanercept may increase the immunosuppressive activities of Cyclosporine.
Modafinil Modafinil The serum concentration of Cyclosporine can be decreased when it is combined with Armodafinil.
Perindopril Perindopril Cyclosporine may decrease the excretion rate of Perindopril which could result in a higher serum level.
Tenofovir Tenofovir Tenofovir may increase the nephrotoxic activities of Cyclosporine.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate The risk or severity of renal failure and hypertension can be increased when Choline magnesium trisalicylate is combined with Cyclosporine.
Sirolimus Sirolimus Sirolimus may increase the immunosuppressive activities of Cyclosporine.
Dutasteride Dutasteride The metabolism of Cyclosporine can be decreased when combined with Dutasteride.
Epinephrine Injection Epinephrine Injection The metabolism of Cyclosporine can be decreased when combined with Epinephrine.
Epirubicin Epirubicin Epirubicin may increase the immunosuppressive activities of Cyclosporine.
Eplerenone Eplerenone The risk or severity of hyperkalemia can be increased when Eplerenone is combined with Cyclosporine.
Escitalopram Escitalopram The metabolism of Cyclosporine can be decreased when combined with Escitalopram.
Olmesartan Olmesartan The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Cyclosporine.
Zonisamide Zonisamide The risk or severity of renal failure can be increased when Zonisamide is combined with Cyclosporine.
Adalimumab Injection Adalimumab Injection The serum concentration of Cyclosporine can be decreased when it is combined with Adalimumab.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Cyclosporine.
Atomoxetine Atomoxetine The metabolism of Atomoxetine can be decreased when combined with Cyclosporine.
Dexmethylphenidate Dexmethylphenidate The risk or severity of hypertension can be increased when Cyclosporine is combined with Dexmethylphenidate.
Ezetimibe Ezetimibe The serum concentration of Cyclosporine can be increased when it is combined with Ezetimibe.
Glatiramer Injection Glatiramer Injection Glatiramer may increase the immunosuppressive activities of Cyclosporine.
Atazanavir Atazanavir The metabolism of Atazanavir can be decreased when combined with Cyclosporine.
Almotriptan Almotriptan The metabolism of Cyclosporine can be decreased when combined with Almotriptan.
Eletriptan Eletriptan The metabolism of Eletriptan can be decreased when combined with Cyclosporine.
Mefloquine Mefloquine The metabolism of Cyclosporine can be decreased when combined with Mefloquine.
Rosuvastatin Rosuvastatin The serum concentration of Rosuvastatin can be increased when it is combined with Cyclosporine.
Vardenafil Vardenafil The metabolism of Vardenafil can be decreased when combined with Cyclosporine.
Alfuzosin Alfuzosin The metabolism of Alfuzosin can be decreased when combined with Cyclosporine.
Aprepitant Aprepitant The metabolism of Aprepitant can be decreased when combined with Cyclosporine.
Emtricitabine Emtricitabine Cyclosporine may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
Memantine Memantine Cyclosporine may decrease the excretion rate of Memantine which could result in a higher serum level.
Tegaserod Tegaserod The metabolism of Tegaserod can be decreased when combined with Cyclosporine.
Tadalafil Tadalafil The metabolism of Tadalafil can be decreased when combined with Cyclosporine.
Frovatriptan Frovatriptan The risk or severity of hypertension can be increased when Cyclosporine is combined with Frovatriptan.
Gemifloxacin Gemifloxacin The risk or severity of nephrotoxicity can be increased when Gemifloxacin is combined with Cyclosporine.
Progesterone Progesterone The metabolism of Cyclosporine can be decreased when combined with Progesterone.
Apomorphine Injection Apomorphine Injection The metabolism of Apomorphine can be decreased when combined with Cyclosporine.
Infliximab Injection Infliximab Injection Infliximab may increase the immunosuppressive activities of Cyclosporine.
Oxandrolone Oxandrolone The risk or severity of liver damage can be increased when Oxandrolone is combined with Cyclosporine.
Protriptyline Protriptyline The metabolism of Cyclosporine can be decreased when combined with Protriptyline.
Rifaximin Rifaximin The serum concentration of Rifaximin can be increased when it is combined with Cyclosporine.
Duloxetine Duloxetine The metabolism of Cyclosporine can be decreased when combined with Duloxetine.
Norethindrone Norethindrone The metabolism of Cyclosporine can be decreased when combined with Norethisterone.
Tinidazole Tinidazole Cyclosporine may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Bosentan Bosentan The serum concentration of Bosentan can be increased when it is combined with Cyclosporine.
Cefditoren Cefditoren Cyclosporine may decrease the excretion rate of Cefdinir which could result in a higher serum level.
Natalizumab Injection Natalizumab Injection Natalizumab may increase the immunosuppressive activities of Cyclosporine.
Cyanocobalamin Injection Cyanocobalamin Injection Cyclosporine may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.
Erlotinib Erlotinib The metabolism of Erlotinib can be decreased when combined with Cyclosporine.
Eszopiclone Eszopiclone The metabolism of Eszopiclone can be decreased when combined with Cyclosporine.
Ganciclovir Ganciclovir Cyclosporine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
Ribavirin Ribavirin Cyclosporine may decrease the excretion rate of Ribavirin which could result in a higher serum level.
Solifenacin Solifenacin The metabolism of Cyclosporine can be decreased when combined with Solifenacin.
Valganciclovir Valganciclovir Cyclosporine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Voriconazole Voriconazole The metabolism of Cyclosporine can be decreased when combined with Voriconazole.
Zoledronic Acid Injection Zoledronic Acid Injection The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cyclosporine is combined with Zoledronic acid.
Adefovir Adefovir The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Adefovir.
Dextroamphetamine Dextroamphetamine The metabolism of Amphetamine can be decreased when combined with Cyclosporine.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection Peginterferon alfa-2a may increase the immunosuppressive activities of Cyclosporine.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) Peginterferon alfa-2b may increase the immunosuppressive activities of Cyclosporine.
Ibandronate Ibandronate The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cyclosporine is combined with Ibandronate.
Isocarboxazid Isocarboxazid The risk or severity of hypertension can be increased when Cyclosporine is combined with Isocarboxazid.
Ramelteon Ramelteon Cyclosporine may decrease the excretion rate of Ramelteon which could result in a higher serum level.
Darifenacin Darifenacin The metabolism of Darifenacin can be decreased when combined with Cyclosporine.
Fentanyl Fentanyl The metabolism of Cyclosporine can be decreased when combined with Fentanyl.
Pregabalin Pregabalin The therapeutic efficacy of Cyclosporine can be decreased when used in combination with Pregabalin.
Deferasirox Deferasirox The metabolism of Cyclosporine can be increased when combined with Deferasirox.
Phenylephrine Phenylephrine The risk or severity of hypertension can be increased when Cyclosporine is combined with Phenylephrine.
Tipranavir Tipranavir The metabolism of Cyclosporine can be decreased when combined with Tipranavir.
Felbamate Felbamate The metabolism of Cyclosporine can be increased when combined with Felbamate.
Ranolazine Ranolazine The serum concentration of Cyclosporine can be increased when it is combined with Ranolazine.
Abatacept Injection Abatacept Injection Abatacept may increase the immunosuppressive activities of Cyclosporine.
Rasagiline Rasagiline Cyclosporine may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Imatinib Imatinib The serum concentration of Cyclosporine can be increased when it is combined with Imatinib.
Sitagliptin Sitagliptin The serum concentration of Cyclosporine can be increased when it is combined with Sitagliptin.
Varenicline Varenicline Cyclosporine may decrease the excretion rate of Varenicline which could result in a higher serum level.
Bevacizumab Injection Bevacizumab Injection Bevacizumab may increase the immunosuppressive activities of Cyclosporine.
Gefitinib Gefitinib The metabolism of Cyclosporine can be decreased when combined with Gefitinib.
Albuterol Albuterol Cyclosporine may decrease the excretion rate of Salbutamol which could result in a higher serum level.
Paliperidone Paliperidone The metabolism of Cyclosporine can be decreased when combined with Paliperidone.
Bortezomib Bortezomib Bortezomib may increase the immunosuppressive activities of Cyclosporine.
Clofarabine Injection Clofarabine Injection Clofarabine may increase the immunosuppressive activities of Cyclosporine.
Hepatitis B Vaccine Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Cyclosporine.
Influenza Vaccine, Inactivated or Recombinant Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Cyclosporine.
Influenza Vaccine, Live Intranasal Influenza Vaccine, Live Intranasal The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Cyclosporine.
Live Shingles (Zoster) Vaccine (ZVL) Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Cyclosporine.
Lubiprostone Lubiprostone Cyclosporine may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Oxaliplatin Injection Oxaliplatin Injection Oxaliplatin may increase the immunosuppressive activities of Cyclosporine.
Posaconazole Posaconazole The metabolism of Posaconazole can be decreased when combined with Cyclosporine.
Primaquine Primaquine The metabolism of Cyclosporine can be decreased when combined with Primaquine.
Rituximab Injection Rituximab Injection Rituximab may increase the immunosuppressive activities of Cyclosporine.
Aliskiren Aliskiren The serum concentration of Aliskiren can be increased when it is combined with Cyclosporine.
Bismuth Subsalicylate Bismuth Subsalicylate Cyclosporine may increase the neurotoxic activities of Bismuth subsalicylate.
Darunavir Darunavir The serum concentration of Cyclosporine can be increased when it is combined with Darunavir.
Pemetrexed Injection Pemetrexed Injection Pemetrexed may increase the immunosuppressive activities of Cyclosporine.
Lisdexamfetamine Lisdexamfetamine The metabolism of Lisdexamfetamine can be decreased when combined with Cyclosporine.
Retapamulin Retapamulin The metabolism of Retapamulin can be decreased when combined with Cyclosporine.
Vorinostat Vorinostat Vorinostat may increase the immunosuppressive activities of Cyclosporine.
Sorafenib Sorafenib Sorafenib may increase the immunosuppressive activities of Cyclosporine.
Sunitinib Sunitinib Sunitinib may increase the immunosuppressive activities of Cyclosporine.
Lapatinib Lapatinib The serum concentration of Cyclosporine can be increased when it is combined with Lapatinib.
Levocetirizine Levocetirizine Cyclosporine may decrease the excretion rate of Levocetirizine which could result in a higher serum level.
Pegaptanib Injection Pegaptanib Injection Cyclosporine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib Dasatinib Dasatinib may increase the immunosuppressive activities of Cyclosporine.
Mexiletine Mexiletine The metabolism of Cyclosporine can be decreased when combined with Mexiletine.
Armodafinil Armodafinil The serum concentration of Cyclosporine can be decreased when it is combined with Armodafinil.
Azacitidine Injection Azacitidine Injection Azacitidine may increase the immunosuppressive activities of Cyclosporine.
Ivermectin Ivermectin The metabolism of Ivermectin can be increased when combined with Cyclosporine.
Temsirolimus Temsirolimus Temsirolimus may increase the immunosuppressive activities of Cyclosporine.
Nelarabine Injection Nelarabine Injection Nelarabine may increase the immunosuppressive activities of Cyclosporine.
Lenalidomide Lenalidomide Lenalidomide may increase the immunosuppressive activities of Cyclosporine.
Nilotinib Nilotinib Nilotinib may increase the immunosuppressive activities of Cyclosporine.
Toremifene Toremifene The serum concentration of Cyclosporine can be increased when it is combined with Toremifene.
Raltegravir Raltegravir The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cyclosporine is combined with Raltegravir.
Bexarotene Bexarotene Bexarotene may increase the immunosuppressive activities of Cyclosporine.
Budesonide Budesonide Budesonide may increase the immunosuppressive activities of Cyclosporine.
Chloramphenicol Injection Chloramphenicol Injection The serum concentration of Cyclosporine can be increased when it is combined with Chloramphenicol.
Decitabine Injection Decitabine Injection Decitabine may increase the immunosuppressive activities of Cyclosporine.
Desmopressin Desmopressin Cyclosporine may decrease the excretion rate of Desmopressin which could result in a higher serum level.
OnabotulinumtoxinA Injection OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Cyclosporine is combined with Botulinum toxin type A.
RimabotulinumtoxinB Injection RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Cyclosporine is combined with Botulinum Toxin Type B.
Doripenem Injection Doripenem Injection Cyclosporine may decrease the excretion rate of Doripenem which could result in a higher serum level.
Etravirine Etravirine The metabolism of Cyclosporine can be increased when combined with Etravirine.
Arsenic Trioxide Injection Arsenic Trioxide Injection Arsenic trioxide may increase the immunosuppressive activities of Cyclosporine.
Mitoxantrone Injection Mitoxantrone Injection The serum concentration of Mitoxantrone can be increased when it is combined with Cyclosporine.
Desvenlafaxine Desvenlafaxine The metabolism of Desvenlafaxine can be decreased when combined with Cyclosporine.
Cevimeline Cevimeline The metabolism of Cyclosporine can be decreased when combined with Cevimeline.
Nebivolol Nebivolol The metabolism of Cyclosporine can be decreased when combined with Nebivolol.
Tretinoin Tretinoin Tretinoin may increase the immunosuppressive activities of Cyclosporine.
Bendamustine Injection Bendamustine Injection Bendamustine may increase the immunosuppressive activities of Cyclosporine.
Pilocarpine Pilocarpine The metabolism of Cyclosporine can be decreased when combined with Pilocarpine.
Flecainide Flecainide The metabolism of Flecainide can be decreased when combined with Cyclosporine.
Certolizumab Injection Certolizumab Injection Certolizumab pegol may increase the immunosuppressive activities of Cyclosporine.
Ixabepilone Injection Ixabepilone Injection Ixabepilone may increase the immunosuppressive activities of Cyclosporine.
Irinotecan Injection Irinotecan Injection Irinotecan may increase the immunosuppressive activities of Cyclosporine.
Daptomycin Injection Daptomycin Injection Cyclosporine may decrease the excretion rate of Daptomycin which could result in a higher serum level.
Estramustine Estramustine Estramustine may increase the immunosuppressive activities of Cyclosporine.
Praziquantel Praziquantel The metabolism of Cyclosporine can be decreased when combined with Praziquantel.
Mitotane Mitotane The metabolism of Cyclosporine can be increased when combined with Mitotane.
Methylnaltrexone Injection Methylnaltrexone Injection Cyclosporine may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab may increase the immunosuppressive activities of Cyclosporine.
Rufinamide Rufinamide The metabolism of Cyclosporine can be increased when combined with Rufinamide.
Silodosin Silodosin The serum concentration of Cyclosporine can be increased when it is combined with Silodosin.
Midazolam Midazolam The serum concentration of Midazolam can be increased when it is combined with Cyclosporine.
Naltrexone Injection Naltrexone Injection The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cyclosporine is combined with Naltrexone.
Dexrazoxane Injection Dexrazoxane Injection Dexrazoxane may increase the immunosuppressive activities of Cyclosporine.
Ibritumomab Injection Ibritumomab Injection Ibritumomab tiuxetan may increase the immunosuppressive activities of Cyclosporine.
Milnacipran Milnacipran The metabolism of Milnacipran can be decreased when combined with Cyclosporine.
Plerixafor Injection Plerixafor Injection Cyclosporine may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Sodium Phosphate Sodium Phosphate Sodium phosphate, monobasic may increase the hyperkalemic activities of Cyclosporine.
Fesoterodine Fesoterodine The metabolism of Cyclosporine can be decreased when combined with Fesoterodine.
Betaxolol Betaxolol The metabolism of Betaxolol can be decreased when combined with Cyclosporine.
Iloperidone Iloperidone The metabolism of Iloperidone can be decreased when combined with Cyclosporine.
Prasugrel Prasugrel Cyclosporine may decrease the excretion rate of Prasugrel which could result in a higher serum level.
Lacosamide Lacosamide The metabolism of Cyclosporine can be decreased when combined with Lacosamide.
Everolimus Everolimus The serum concentration of Everolimus can be increased when it is combined with Cyclosporine.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The serum concentration of Cyclosporine can be increased when it is combined with Tolvaptan.
Dronedarone Dronedarone The serum concentration of Dronedarone can be increased when it is combined with Cyclosporine.
AbobotulinumtoxinA Injection AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Cyclosporine is combined with Botulinum toxin type A.
Pralatrexate Injection Pralatrexate Injection Pralatrexate may increase the immunosuppressive activities of Cyclosporine.
Palonosetron Injection Palonosetron Injection The metabolism of Cyclosporine can be decreased when combined with Palonosetron.
Saxagliptin Saxagliptin The metabolism of Cyclosporine can be decreased when combined with Saxagliptin.
Telavancin Injection Telavancin Injection Cyclosporine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Romidepsin Injection Romidepsin Injection The metabolism of Cyclosporine can be decreased when combined with Romidepsin.
Tapentadol Tapentadol The metabolism of Tapentadol can be decreased when combined with Cyclosporine.
Topotecan Topotecan Topotecan may increase the immunosuppressive activities of Cyclosporine.
Golimumab Injection Golimumab Injection Golimumab may increase the immunosuppressive activities of Cyclosporine.
Pazopanib Pazopanib Pazopanib may increase the immunosuppressive activities of Cyclosporine.
Asenapine Asenapine The risk or severity of hypertension can be increased when Cyclosporine is combined with Asenapine.
Vigabatrin Vigabatrin The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Cyclosporine.
Pitavastatin Pitavastatin The serum concentration of Pitavastatin can be increased when it is combined with Cyclosporine.
Albendazole Albendazole The metabolism of Cyclosporine can be decreased when combined with Albendazole.
Levonorgestrel Levonorgestrel The metabolism of Levonorgestrel can be decreased when combined with Cyclosporine.
Oxymorphone Oxymorphone The metabolism of Cyclosporine can be decreased when combined with Oxymorphone.
Denosumab Injection Denosumab Injection Denosumab may increase the immunosuppressive activities of Cyclosporine.
Tocilizumab Injection Tocilizumab Injection Tocilizumab may increase the immunosuppressive activities of Cyclosporine.
Dalfampridine Dalfampridine The risk or severity of seizure can be increased when Cyclosporine is combined with Dalfampridine.
Fingolimod Fingolimod Fingolimod may increase the immunosuppressive activities of Cyclosporine.
Eribulin Injection Eribulin Injection Eribulin may increase the immunosuppressive activities of Cyclosporine.
IncobotulinumtoxinA Injection IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Cyclosporine is combined with Botulinum toxin type A.
Cabazitaxel Injection Cabazitaxel Injection Cabazitaxel may increase the immunosuppressive activities of Cyclosporine.
Ceftaroline Injection Ceftaroline Injection The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Ceftaroline fosamil.
Lurasidone Lurasidone The metabolism of Lurasidone can be decreased when combined with Cyclosporine.
Acetaminophen Injection Acetaminophen Injection The metabolism of Cyclosporine can be decreased when combined with Acetaminophen.
Vilazodone Vilazodone The metabolism of Cyclosporine can be decreased when combined with Vilazodone.
Ipilimumab Injection Ipilimumab Injection Cyclosporine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection Aldesleukin may increase the immunosuppressive activities of Cyclosporine.
Sipuleucel-T Injection Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Cyclosporine.
Terbutaline Injection Terbutaline Injection Cyclosporine may decrease the excretion rate of Terbutaline which could result in a higher serum level.
Belimumab Injection Belimumab Injection Belimumab may increase the immunosuppressive activities of Cyclosporine.
Azilsartan Azilsartan The risk or severity of hyperkalemia can be increased when Azilsartan medoxomil is combined with Cyclosporine.
Busulfan Injection Busulfan Injection Busulfan may increase the immunosuppressive activities of Cyclosporine.
Roflumilast Roflumilast Roflumilast may increase the immunosuppressive activities of Cyclosporine.
Linagliptin Linagliptin The serum concentration of Cyclosporine can be increased when it is combined with Linagliptin.
Rilpivirine Rilpivirine The metabolism of Cyclosporine can be decreased when combined with Rilpivirine.
Telaprevir Telaprevir The serum concentration of Cyclosporine can be increased when it is combined with Glecaprevir.
Potassium Iodide Potassium Iodide Potassium Iodide may increase the hyperkalemic activities of Cyclosporine.
Cyclophosphamide Injection Cyclophosphamide Injection The serum concentration of Cyclosporine can be decreased when it is combined with Cyclophosphamide.
Rivaroxaban Rivaroxaban The metabolism of Rivaroxaban can be decreased when combined with Cyclosporine.
Ticagrelor Ticagrelor The serum concentration of Ticagrelor can be increased when it is combined with Cyclosporine.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection Brentuximab vedotin may increase the immunosuppressive activities of Cyclosporine.
Ruxolitinib Ruxolitinib Ruxolitinib may increase the immunosuppressive activities of Cyclosporine.
Vandetanib Vandetanib The serum concentration of Cyclosporine can be increased when it is combined with Vandetanib.
Clobazam Clobazam The metabolism of Cyclosporine can be increased when combined with Clobazam.
Vemurafenib Vemurafenib The serum concentration of Cyclosporine can be increased when it is combined with Vemurafenib.
Belatacept Injection Belatacept Injection Belatacept may increase the immunosuppressive activities of Cyclosporine.
Ivacaftor Ivacaftor The metabolism of Cyclosporine can be decreased when combined with Ivacaftor.
Basiliximab Injection Basiliximab Injection Basiliximab may increase the immunosuppressive activities of Cyclosporine.
Deferiprone Deferiprone Cyclosporine may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib Axitinib The metabolism of Cyclosporine can be decreased when combined with Axitinib.
Crizotinib Crizotinib The serum concentration of Cyclosporine can be increased when it is combined with Crizotinib.
Melphalan Injection Melphalan Injection Melphalan may increase the nephrotoxic activities of Cyclosporine.
Cabergoline Cabergoline The metabolism of Cyclosporine can be decreased when combined with Cabergoline.
Naloxone Injection Naloxone Injection The metabolism of Cyclosporine can be decreased when combined with Naloxone.
Ambrisentan Ambrisentan The serum concentration of Ambrisentan can be increased when it is combined with Cyclosporine.
Eculizumab Injection Eculizumab Injection Eculizumab may increase the immunosuppressive activities of Cyclosporine.
Fondaparinux Injection Fondaparinux Injection Cyclosporine may decrease the excretion rate of Fondaparinux which could result in a higher serum level.
Ezogabine Ezogabine The therapeutic efficacy of Tiagabine can be decreased when used in combination with Cyclosporine.
Carfilzomib Injection Carfilzomib Injection Carfilzomib may increase the immunosuppressive activities of Cyclosporine.
Iloprost Iloprost The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cyclosporine is combined with Iloprost.
Enzalutamide Enzalutamide The serum concentration of Cyclosporine can be decreased when it is combined with Enzalutamide.
Mirabegron Mirabegron The metabolism of Cyclosporine can be decreased when combined with Mirabegron.
Regorafenib Regorafenib The serum concentration of Cyclosporine can be increased when it is combined with Regorafenib.
Bosutinib Bosutinib Bosutinib may increase the immunosuppressive activities of Cyclosporine.
Corticotropin, Repository Injection Corticotropin, Repository Injection Corticotropin may increase the immunosuppressive activities of Cyclosporine.
Teriflunomide Teriflunomide Teriflunomide may increase the immunosuppressive activities of Cyclosporine.
Teduglutide Injection Teduglutide Injection Cyclosporine may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Tofacitinib Tofacitinib Tofacitinib may increase the immunosuppressive activities of Cyclosporine.
Alogliptin Alogliptin The metabolism of Cyclosporine can be decreased when combined with Alogliptin.
Dimethyl Fumarate Dimethyl Fumarate Dimethyl fumarate may increase the immunosuppressive activities of Cyclosporine.
Ponatinib Ponatinib Ponatinib may increase the immunosuppressive activities of Cyclosporine.
Pomalidomide Pomalidomide Pomalidomide may increase the immunosuppressive activities of Cyclosporine.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection Trastuzumab emtansine may increase the immunosuppressive activities of Cyclosporine.
Apixaban Apixaban The metabolism of Cyclosporine can be decreased when combined with Apixaban.
Canagliflozin Canagliflozin The serum concentration of Cyclosporine can be increased when it is combined with Canagliflozin.
Methazolamide Methazolamide The risk or severity of renal failure can be increased when Methazolamide is combined with Cyclosporine.
Dabrafenib Dabrafenib The metabolism of Cyclosporine can be increased when combined with Dabrafenib.
Trametinib Trametinib The metabolism of Cyclosporine can be increased when combined with Trametinib.
Dolutegravir Dolutegravir The serum concentration of Cyclosporine can be increased when it is combined with Dolutegravir.
Afatinib Afatinib The serum concentration of Cyclosporine can be increased when it is combined with Afatinib.
Levomilnacipran Levomilnacipran The metabolism of Levomilnacipran can be decreased when combined with Cyclosporine.
Ertapenem Injection Ertapenem Injection Cyclosporine may decrease the excretion rate of Ertapenem which could result in a higher serum level.
Tigecycline Injection Tigecycline Injection The risk or severity of neuromuscular blockade can be increased when Cyclosporine is combined with Tigecycline.
Vortioxetine Vortioxetine The metabolism of Cyclosporine can be decreased when combined with Vortioxetine.
Perampanel Perampanel The metabolism of Perampanel can be increased when combined with Cyclosporine.
Ibrutinib Ibrutinib Ibrutinib may increase the immunosuppressive activities of Cyclosporine.
Lomitapide Lomitapide The serum concentration of Lomitapide can be increased when it is combined with Cyclosporine.
Avanafil Avanafil The metabolism of Avanafil can be decreased when combined with Cyclosporine.
Ketorolac Injection Ketorolac Injection The risk or severity of renal failure and hypertension can be increased when Ketorolac is combined with Cyclosporine.
Obinutuzumab Injection Obinutuzumab Injection Obinutuzumab may increase the immunosuppressive activities of Cyclosporine.
Simeprevir Simeprevir The serum concentration of Cyclosporine can be increased when it is combined with Simeprevir.
Sofosbuvir Sofosbuvir The serum concentration of Cyclosporine can be increased when it is combined with Sofosbuvir.
Dapagliflozin Dapagliflozin The metabolism of Cyclosporine can be decreased when combined with Dapagliflozin.
Apremilast Apremilast Apremilast may increase the immunosuppressive activities of Cyclosporine.
Droxidopa Droxidopa Cyclosporine may decrease the excretion rate of Droxidopa which could result in a higher serum level.
Ceritinib Ceritinib The metabolism of Cyclosporine can be decreased when combined with Ceritinib.
Siltuximab Injection Siltuximab Injection Siltuximab may increase the immunosuppressive activities of Cyclosporine.
Eslicarbazepine Eslicarbazepine The metabolism of Cyclosporine can be increased when combined with Eslicarbazepine.
Vedolizumab Injection Vedolizumab Injection Vedolizumab may increase the immunosuppressive activities of Cyclosporine.
Belinostat Injection Belinostat Injection Belinostat may increase the immunosuppressive activities of Cyclosporine.
Idelalisib Idelalisib Idelalisib may increase the immunosuppressive activities of Cyclosporine.
Testosterone Injection Testosterone Injection The risk or severity of liver damage can be increased when Testosterone is combined with Cyclosporine.
Oritavancin Injection Oritavancin Injection The metabolism of Cyclosporine can be increased when combined with Oritavancin.
Vorapaxar Vorapaxar The serum concentration of Cyclosporine can be increased when it is combined with Vorapaxar.
Hydrocodone Hydrocodone The metabolism of Hydrocodone can be decreased when combined with Cyclosporine.
Suvorexant Suvorexant The serum concentration of Cyclosporine can be increased when it is combined with Suvorexant.
Edoxaban Edoxaban The serum concentration of Cyclosporine can be increased when it is combined with Edoxaban.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection Peginterferon beta-1a may increase the immunosuppressive activities of Cyclosporine.
Olaparib Olaparib Olaparib may increase the immunosuppressive activities of Cyclosporine.
Blinatumomab Injection Blinatumomab Injection Blinatumomab may increase the immunosuppressive activities of Cyclosporine.
Caspofungin Injection Caspofungin Injection The risk or severity of adverse effects can be increased when Cyclosporine is combined with Caspofungin.
Methamphetamine Methamphetamine The metabolism of Metamfetamine can be decreased when combined with Cyclosporine.
Tasimelteon Tasimelteon The metabolism of Cyclosporine can be decreased when combined with Tasimelteon.
Riociguat Riociguat Cyclosporine may decrease the excretion rate of Riociguat which could result in a higher serum level.
Lanreotide Injection Lanreotide Injection The bioavailability of Cyclosporine can be decreased when combined with Lanreotide.
Pirfenidone Pirfenidone Pirfenidone may increase the immunosuppressive activities of Cyclosporine.
Nintedanib Nintedanib The metabolism of Cyclosporine can be decreased when combined with Nintedanib.
Secukinumab Injection Secukinumab Injection Secukinumab may increase the immunosuppressive activities of Cyclosporine.
Risperidone Injection Risperidone Injection The metabolism of Cyclosporine can be decreased when combined with Risperidone.
Palbociclib Palbociclib Palbociclib may increase the immunosuppressive activities of Cyclosporine.
Lenvatinib Lenvatinib The metabolism of Cyclosporine can be increased when combined with Lenvatinib.
Naloxegol Naloxegol The metabolism of Naloxegol can be decreased when combined with Cyclosporine.
Panobinostat Panobinostat Panobinostat may increase the immunosuppressive activities of Cyclosporine.
Dinutuximab Injection Dinutuximab Injection Dinutuximab may increase the immunosuppressive activities of Cyclosporine.
Haloperidol Injection Haloperidol Injection The serum concentration of Cyclosporine can be increased when it is combined with Haloperidol.
Ivabradine Ivabradine The metabolism of Cyclosporine can be decreased when combined with Ivabradine.
Amiloride Amiloride The risk or severity of hyperkalemia can be increased when Amiloride is combined with Cyclosporine.
Isavuconazonium Injection Isavuconazonium Injection The serum concentration of Cyclosporine can be increased when it is combined with Isavuconazonium.
Macitentan Macitentan Cyclosporine may decrease the excretion rate of Macitentan which could result in a higher serum level.
Sonidegib Sonidegib The metabolism of Cyclosporine can be decreased when combined with Sonidegib.
Flibanserin Flibanserin The metabolism of Cyclosporine can be decreased when combined with Flibanserin.
Rolapitant Rolapitant The serum concentration of Cyclosporine can be increased when it is combined with Rolapitant.
Prednisolone Prednisolone Prednisolone may increase the immunosuppressive activities of Cyclosporine.
Daclatasvir Daclatasvir The serum concentration of Cyclosporine can be increased when it is combined with Daclatasvir.
Brexpiprazole Brexpiprazole The metabolism of Brexpiprazole can be decreased when combined with Cyclosporine.
Ziprasidone Injection Ziprasidone Injection The metabolism of Cyclosporine can be decreased when combined with Ziprasidone.
Cariprazine Cariprazine The metabolism of Cyclosporine can be decreased when combined with Cariprazine.
Penicillin G Procaine Injection Penicillin G Procaine Injection Cyclosporine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Eluxadoline Eluxadoline The serum concentration of Eluxadoline can be increased when it is combined with Cyclosporine.
Cobimetinib Cobimetinib The metabolism of Cyclosporine can be decreased when combined with Cobimetinib.
Mepolizumab Injection Mepolizumab Injection Mepolizumab may increase the immunosuppressive activities of Cyclosporine.
Trabectedin Injection Trabectedin Injection Trabectedin may increase the immunosuppressive activities of Cyclosporine.
Osimertinib Osimertinib The metabolism of Cyclosporine can be increased when combined with Osimertinib.
Alectinib Alectinib The metabolism of Alectinib can be decreased when combined with Cyclosporine.
Ixazomib Ixazomib The metabolism of Ixazomib can be decreased when combined with Cyclosporine.
Rifapentine Rifapentine The metabolism of Cyclosporine can be increased when combined with Rifapentine.
Lesinurad Lesinurad The metabolism of Lesinurad can be increased when combined with Cyclosporine.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection Amphotericin B may increase the nephrotoxic activities of Cyclosporine.
Dexamethasone Injection Dexamethasone Injection Dexamethasone may increase the immunosuppressive activities of Cyclosporine.
Ixekizumab Injection Ixekizumab Injection Ixekizumab may increase the immunosuppressive activities of Cyclosporine.
Brivaracetam Injection Brivaracetam Injection The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Cyclosporine.
Venetoclax Venetoclax The serum concentration of Cyclosporine can be increased when it is combined with Venetoclax.
Cobicistat Cobicistat The serum concentration of Cyclosporine can be increased when it is combined with Cobicistat.
Midodrine Midodrine The risk or severity of hypertension can be increased when Cyclosporine is combined with Midodrine.
Selexipag Selexipag The serum concentration of Cyclosporine can be increased when it is combined with Selexipag.
Pimavanserin Pimavanserin Cyclosporine may increase the neurotoxic activities of Pimavanserin.
Obeticholic Acid Obeticholic Acid The risk or severity of adverse effects can be increased when Cyclosporine is combined with Obeticholic acid.
Diphenhydramine Injection Diphenhydramine Injection The metabolism of Diphenhydramine can be decreased when combined with Cyclosporine.
Furosemide Injection Furosemide Injection The risk or severity of gouty arthritis can be increased when Cyclosporine is combined with Furosemide.
Rucaparib Rucaparib The metabolism of Cyclosporine can be decreased when combined with Rucaparib.
Lixisenatide Injection Lixisenatide Injection Cyclosporine may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Ribociclib Ribociclib The metabolism of Cyclosporine can be decreased when combined with Ribociclib.
Brodalumab Injection Brodalumab Injection Brodalumab may increase the immunosuppressive activities of Cyclosporine.
Brigatinib Brigatinib The metabolism of Cyclosporine can be increased when combined with Brigatinib.
Doxepin (Insomnia) Doxepin (Insomnia) The metabolism of Doxepin can be decreased when combined with Cyclosporine.
Deutetrabenazine Deutetrabenazine The metabolism of Cyclosporine can be decreased when combined with Deutetrabenazine.
Valbenazine Valbenazine The metabolism of Cyclosporine can be decreased when combined with Valbenazine.
Deflazacort Deflazacort Deflazacort may increase the immunosuppressive activities of Cyclosporine.
Safinamide Safinamide The metabolism of Cyclosporine can be decreased when combined with Safinamide.
Ocrelizumab Injection Ocrelizumab Injection Ocrelizumab may increase the immunosuppressive activities of Cyclosporine.
Edaravone Injection Edaravone Injection The excretion of Edaravone can be decreased when combined with Cyclosporine.
Naldemedine Naldemedine Cyclosporine may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Sarilumab Injection Sarilumab Injection Sarilumab may increase the immunosuppressive activities of Cyclosporine.
Midostaurin Midostaurin The metabolism of Cyclosporine can be increased when combined with Midostaurin.
Neratinib Neratinib The serum concentration of Cyclosporine can be increased when it is combined with Neratinib.
Guselkumab Injection Guselkumab Injection Guselkumab may increase the immunosuppressive activities of Cyclosporine.
Enasidenib Enasidenib The metabolism of Cyclosporine can be decreased when combined with Enasidenib.
Inotuzumab Ozogamicin Injection Inotuzumab Ozogamicin Injection The serum concentration of Cyclosporine can be increased when it is combined with Inotuzumab ozogamicin.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Fosaprepitant can be increased when combined with Cyclosporine.
Benznidazole Benznidazole Cyclosporine may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Copanlisib Injection Copanlisib Injection The metabolism of Cyclosporine can be decreased when combined with Copanlisib.
Delafloxacin Delafloxacin The risk or severity of nephrotoxicity can be increased when Delafloxacin is combined with Cyclosporine.
Abemaciclib Abemaciclib The metabolism of Abemaciclib can be decreased when combined with Cyclosporine.
Betrixaban Betrixaban The serum concentration of Cyclosporine can be increased when it is combined with Betrixaban.
Acalabrutinib Acalabrutinib The metabolism of Cyclosporine can be decreased when combined with Acalabrutinib.
Gemtuzumab Ozogamicin Injection Gemtuzumab Ozogamicin Injection Gemtuzumab ozogamicin may increase the immunosuppressive activities of Cyclosporine.
Letermovir Letermovir The metabolism of Cyclosporine can be decreased when combined with Letermovir.
Tetrabenazine Tetrabenazine The metabolism of Tetrabenazine can be decreased when combined with Cyclosporine.
Ertugliflozin Ertugliflozin The serum concentration of Cyclosporine can be increased when it is combined with Ertugliflozin.
Buprenorphine Injection Buprenorphine Injection The metabolism of Cyclosporine can be decreased when combined with Buprenorphine.
Apalutamide Apalutamide The serum concentration of Cyclosporine can be decreased when it is combined with Apalutamide.
Penicillamine Penicillamine Penicillamine may increase the immunosuppressive activities of Cyclosporine.
Fostamatinib Fostamatinib The metabolism of Cyclosporine can be decreased when combined with Fostamatinib.
Avatrombopag Avatrombopag The serum concentration of Cyclosporine can be increased when it is combined with Avatrombopag.
Baricitinib Baricitinib Baricitinib may increase the immunosuppressive activities of Cyclosporine.
Lofexidine Lofexidine The metabolism of Lofexidine can be decreased when combined with Cyclosporine.
Plazomicin Injection Plazomicin Injection Cyclosporine may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Eliglustat Eliglustat The metabolism of Eliglustat can be decreased when combined with Cyclosporine.
Encorafenib Encorafenib The metabolism of Cyclosporine can be decreased when combined with Encorafenib.
Binimetinib Binimetinib The serum concentration of Binimetinib can be increased when it is combined with Cyclosporine.
Ivosidenib Ivosidenib The serum concentration of Cyclosporine can be increased when it is combined with Ivosidenib.
Lusutrombopag Lusutrombopag Cyclosporine may decrease the excretion rate of Lusutrombopag which could result in a higher serum level.
Elagolix Elagolix The metabolism of Elagolix can be decreased when combined with Cyclosporine.
Doravirine Doravirine The metabolism of Cyclosporine can be decreased when combined with Doravirine.
Tafenoquine Tafenoquine The metabolism of Tafenoquine can be decreased when combined with Cyclosporine.
Cannabidiol Cannabidiol The metabolism of Cannabidiol can be decreased when combined with Cyclosporine.
Dacomitinib Dacomitinib The metabolism of Cyclosporine can be decreased when combined with Dacomitinib.
Duvelisib Duvelisib The metabolism of Cyclosporine can be decreased when combined with Duvelisib.
Omadacycline Omadacycline The serum concentration of Cyclosporine can be increased when it is combined with Omadacycline.
Sarecycline Sarecycline The serum concentration of Cyclosporine can be increased when it is combined with Sarecycline.
Stiripentol Stiripentol The metabolism of Cyclosporine can be decreased when combined with Stiripentol.
Talazoparib Talazoparib The serum concentration of Cyclosporine can be increased when it is combined with Talazoparib.
Gilteritinib Gilteritinib The metabolism of Cyclosporine can be decreased when combined with Gilteritinib.
Glasdegib Glasdegib The serum concentration of Cyclosporine can be increased when it is combined with Glasdegib.
Lorlatinib Lorlatinib The metabolism of Cyclosporine can be decreased when combined with Lorlatinib.
Larotrectinib Larotrectinib The serum concentration of Cyclosporine can be increased when it is combined with Larotrectinib.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection Paclitaxel may increase the immunosuppressive activities of Cyclosporine.
Rifamycin Rifamycin The metabolism of Cyclosporine can be increased when combined with Rifamycin.
Prucalopride Prucalopride The serum concentration of Prucalopride can be increased when it is combined with Cyclosporine.
Ravulizumab-cwvz Injection Ravulizumab-cwvz Injection Ravulizumab may increase the immunosuppressive activities of Cyclosporine.
Magnesium Citrate Magnesium Citrate The risk or severity of neuromuscular blockade can be increased when Cyclosporine is combined with Magnesium citrate.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection Emapalumab may increase the immunosuppressive activities of Cyclosporine.
Siponimod Siponimod Siponimod may increase the immunosuppressive activities of Cyclosporine.
Acyclovir Ophthalmic Acyclovir Ophthalmic Cyclosporine may decrease the excretion rate of Acyclovir which could result in a higher serum level.
Erdafitinib Erdafitinib The serum concentration of Cyclosporine can be increased when it is combined with Erdafitinib.
Esomeprazole Injection Esomeprazole Injection The serum concentration of Cyclosporine can be increased when it is combined with Esomeprazole.
Risankizumab-rzaa Injection Risankizumab-rzaa Injection Risankizumab may increase the immunosuppressive activities of Cyclosporine.
Alpelisib Alpelisib The serum concentration of Alpelisib can be increased when it is combined with Cyclosporine.
Brexanolone Injection Brexanolone Injection The therapeutic efficacy of Brexanolone can be decreased when used in combination with Cyclosporine.
Cladribine Cladribine Cladribine may increase the immunosuppressive activities of Cyclosporine.
Solriamfetol Solriamfetol The risk or severity of hypertension can be increased when Solriamfetol is combined with Cyclosporine.
Darolutamide Darolutamide Cyclosporine may decrease the excretion rate of Darolutamide which could result in a higher serum level.
Triclabendazole Triclabendazole The metabolism of Cyclosporine can be decreased when combined with Triclabendazole.
Entrectinib Entrectinib The metabolism of Entrectinib can be decreased when combined with Cyclosporine.
Pexidartinib Pexidartinib The metabolism of Pexidartinib can be decreased when combined with Cyclosporine.
Istradefylline Istradefylline The metabolism of Istradefylline can be decreased when combined with Cyclosporine.
Pitolisant Pitolisant The serum concentration of Cyclosporine can be decreased when it is combined with Pitolisant.
Pretomanid Pretomanid The serum concentration of Pretomanid can be increased when it is combined with Cyclosporine.
Fedratinib Fedratinib The serum concentration of Fedratinib can be increased when it is combined with Cyclosporine.
Lefamulin Lefamulin The serum concentration of Lefamulin can be increased when it is combined with Cyclosporine.
Phenytoin Injection Phenytoin Injection The serum concentration of Cyclosporine can be decreased when it is combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The serum concentration of Cyclosporine can be decreased when it is combined with Fosphenytoin.
Enfortumab vedotin-ejfv Injection Enfortumab vedotin-ejfv Injection The serum concentration of Cyclosporine can be increased when it is combined with Enfortumab vedotin.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Cyclosporine.
Voxelotor Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Cyclosporine.
Lumateperone Lumateperone The serum concentration of Lumateperone can be increased when it is combined with Cyclosporine.
Lasmiditan Lasmiditan The serum concentration of Cyclosporine can be increased when it is combined with Lasmiditan.
Ubrogepant Ubrogepant The serum concentration of Ubrogepant can be increased when it is combined with Cyclosporine.
Tazemetostat Tazemetostat The metabolism of Tazemetostat can be decreased when combined with Cyclosporine.
Bempedoic Acid Bempedoic Acid The excretion of Bempedoic acid can be decreased when combined with Cyclosporine.
Cenobamate Cenobamate The serum concentration of Cenobamate can be decreased when it is combined with Cyclosporine.
Pemigatinib Pemigatinib The metabolism of Pemigatinib can be decreased when combined with Cyclosporine.
Ozanimod Ozanimod Ozanimod may increase the immunosuppressive activities of Cyclosporine.
Selumetinib Selumetinib The serum concentration of Selumetinib can be increased when it is combined with Cyclosporine.
Rimegepant Rimegepant The serum concentration of Rimegepant can be increased when it is combined with Cyclosporine.
Tucatinib Tucatinib Cyclosporine may decrease the excretion rate of Tucatinib which could result in a higher serum level.
Remdesivir Injection Remdesivir Injection The serum concentration of Remdesivir can be increased when it is combined with Cyclosporine.
Ripretinib Ripretinib The serum concentration of Ripretinib can be increased when it is combined with Cyclosporine.
Selpercatinib Selpercatinib The risk or severity of hypertension can be increased when Cyclosporine is combined with Selpercatinib.
Capmatinib Capmatinib The serum concentration of Cyclosporine can be increased when it is combined with Capmatinib.
Lemborexant Lemborexant The metabolism of Lemborexant can be decreased when combined with Cyclosporine.
Fostemsavir Fostemsavir Cyclosporine may decrease the excretion rate of Fostemsavir which could result in a higher serum level.
Lurbinectedin Injection Lurbinectedin Injection The serum concentration of Lurbinectedin can be increased when it is combined with Cyclosporine.
Octreotide Octreotide The serum concentration of Cyclosporine can be increased when it is combined with Octreotide.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection Cyclosporine may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.
Pralsetinib Pralsetinib The serum concentration of Pralsetinib can be increased when it is combined with Cyclosporine.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Cyclosporine can be decreased when it is combined with Satralizumab.
Naxitamab-gqgk Injection Naxitamab-gqgk Injection The risk or severity of hypertension can be increased when Cyclosporine is combined with Naxitamab.
Relugolix Relugolix The serum concentration of Relugolix can be increased when it is combined with Cyclosporine.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Cyclosporine can be decreased when combined with Drospirenone.
Viloxazine Viloxazine Cyclosporine may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Vitamin E (Alpha-Tocopherol) Vitamin E (Alpha-Tocopherol) The serum concentration of Cyclosporine can be decreased when it is combined with Vitamin E.
Tobramycin Injection Tobramycin Injection Cyclosporine may decrease the excretion rate of Tobramycin which could result in a higher serum level.
Theophylline Theophylline The metabolism of Theophylline can be decreased when combined with Cyclosporine.
Fenoprofen Fenoprofen The risk or severity of renal failure and hypertension can be increased when Fenoprofen is combined with Cyclosporine.
Indomethacin Indomethacin Indomethacin may increase the immunosuppressive activities of Cyclosporine.
Mefenamic Acid Mefenamic Acid The risk or severity of renal failure and hypertension can be increased when Mefenamic acid is combined with Cyclosporine.
Naproxen Naproxen The risk or severity of renal failure and hypertension can be increased when Naproxen is combined with Cyclosporine.
Tolmetin Tolmetin The risk or severity of renal failure and hypertension can be increased when Tolmetin is combined with Cyclosporine.
Sulindac Sulindac The risk or severity of renal failure and hypertension can be increased when Sulindac is combined with Cyclosporine.
Trazodone Trazodone The metabolism of Cyclosporine can be decreased when combined with Trazodone.
Isotretinoin Isotretinoin Cyclosporine may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Sucralfate Sucralfate Cyclosporine may decrease the excretion rate of Sucralfate which could result in a higher serum level.
Hydroxyurea Hydroxyurea Hydroxyurea may increase the immunosuppressive activities of Cyclosporine.
Floxuridine Floxuridine Floxuridine may increase the immunosuppressive activities of Cyclosporine.
Phenobarbital Phenobarbital The metabolism of Cyclosporine can be increased when combined with Phenobarbital.
Metaxalone Metaxalone Cyclosporine may decrease the excretion rate of Metaxalone which could result in a higher serum level.
Methotrexate Injection Methotrexate Injection The serum concentration of Methotrexate can be increased when it is combined with Cyclosporine.
Primidone Primidone The metabolism of Cyclosporine can be increased when combined with Primidone.
Methsuximide Methsuximide The therapeutic efficacy of Methsuximide can be decreased when used in combination with Cyclosporine.
Diethylpropion Diethylpropion The risk or severity of hypertension can be increased when Cyclosporine is combined with Diethylpropion.
Chlorpromazine Chlorpromazine The metabolism of Cyclosporine can be decreased when combined with Chlorpromazine.
Diazepam Diazepam The metabolism of Cyclosporine can be decreased when combined with Diazepam.
Oxazepam Oxazepam Cyclosporine may decrease the excretion rate of Oxazepam which could result in a higher serum level.
Flurazepam Flurazepam Cyclosporine may decrease the excretion rate of Flurazepam which could result in a higher serum level.
Clorazepate Clorazepate Cyclosporine may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.
Lorazepam Lorazepam The metabolism of Cyclosporine can be decreased when combined with Lorazepam.
Phenoxybenzamine Phenoxybenzamine The risk or severity of hypertension can be increased when Cyclosporine is combined with Phenoxybenzamine.
Carmustine Carmustine Carmustine may increase the immunosuppressive activities of Cyclosporine.
Amantadine Amantadine Cyclosporine may decrease the excretion rate of Amantadine which could result in a higher serum level.
Codeine Codeine The metabolism of Codeine can be decreased when combined with Cyclosporine.
Bromocriptine Bromocriptine The serum concentration of Cyclosporine can be increased when it is combined with Bromocriptine.
Metaproterenol Metaproterenol The risk or severity of hypertension can be increased when Cyclosporine is combined with Orciprenaline.
Tranylcypromine Tranylcypromine The metabolism of Cyclosporine can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine The metabolism of Cyclosporine can be decreased when combined with Phenelzine.
Procarbazine Procarbazine Procarbazine may increase the immunosuppressive activities of Cyclosporine.
Ergoloid Mesylates Ergoloid Mesylates The risk or severity of hypertension can be increased when Cyclosporine is combined with Ergoloid mesylate.
Tetracycline Tetracycline The metabolism of Cyclosporine can be decreased when combined with Tetracycline.
Thioguanine Thioguanine Tioguanine may increase the immunosuppressive activities of Cyclosporine.
Minocycline Minocycline The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cyclosporine is combined with Minocycline.
Demeclocycline Demeclocycline The risk or severity of neuromuscular blockade can be increased when Cyclosporine is combined with Demeclocycline.
Prochlorperazine Prochlorperazine The metabolism of Cyclosporine can be decreased when combined with Prochlorperazine.
Thioridazine Thioridazine The metabolism of Thioridazine can be decreased when combined with Cyclosporine.
Trifluoperazine Trifluoperazine The risk or severity of hypertension can be increased when Cyclosporine is combined with Trifluoperazine.
Bleomycin Bleomycin Bleomycin may increase the immunosuppressive activities of Cyclosporine.
Dapsone Dapsone The metabolism of Cyclosporine can be decreased when combined with Dapsone.
Sulfadiazine Sulfadiazine The risk or severity of renal failure can be increased when Sulfadiazine is combined with Cyclosporine.
Oxycodone Oxycodone The metabolism of Cyclosporine can be decreased when combined with Oxycodone.
Methadone Methadone The metabolism of Cyclosporine can be decreased when combined with Methadone.
Oxybutynin Oxybutynin The metabolism of Cyclosporine can be decreased when combined with Oxybutynin.
Benztropine Benztropine The metabolism of Benzatropine can be decreased when combined with Cyclosporine.
Maprotiline Maprotiline The metabolism of Maprotiline can be decreased when combined with Cyclosporine.
Ibuprofen Ibuprofen The risk or severity of renal failure and hypertension can be increased when Ibuprofen is combined with Cyclosporine.
Orphenadrine Orphenadrine The metabolism of Cyclosporine can be decreased when combined with Orphenadrine.
Perphenazine Perphenazine The metabolism of Cyclosporine can be decreased when combined with Perphenazine.
Azathioprine Azathioprine Azathioprine may increase the immunosuppressive activities of Cyclosporine.
Fluphenazine Fluphenazine Cyclosporine may increase the neurotoxic activities of Fluphenazine.
Phentermine Phentermine The metabolism of Cyclosporine can be decreased when combined with Phentermine.
Methylphenidate Methylphenidate Cyclosporine may decrease the excretion rate of Methylphenidate which could result in a higher serum level.
Amoxapine Amoxapine The metabolism of Cyclosporine can be decreased when combined with Amoxapine.
Sulfasalazine Sulfasalazine Sulfasalazine may increase the immunosuppressive activities of Cyclosporine.
Hydrocortisone Hydrocortisone Hydrocortisone may increase the immunosuppressive activities of Cyclosporine.
Lomustine Lomustine Lomustine may increase the immunosuppressive activities of Cyclosporine.
Doxorubicin Doxorubicin The serum concentration of Doxorubicin can be increased when it is combined with Cyclosporine.
Cytarabine Cytarabine Cytarabine may increase the immunosuppressive activities of Cyclosporine.
Mechlorethamine Mechlorethamine Mechlorethamine may increase the immunosuppressive activities of Cyclosporine.
Dactinomycin Dactinomycin Dactinomycin may increase the immunosuppressive activities of Cyclosporine.
Phenazopyridine Phenazopyridine The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Phenazopyridine.
Carbamazepine Carbamazepine The serum concentration of Cyclosporine can be decreased when it is combined with Carbamazepine.
Molindone Molindone Cyclosporine may increase the neurotoxic activities of Molindone.
Methyldopa Methyldopa Cyclosporine may decrease the excretion rate of Methyldopa which could result in a higher serum level.
Clonidine Clonidine The metabolism of Clonidine can be decreased when combined with Cyclosporine.
Prazosin Prazosin Cyclosporine may decrease the excretion rate of Prazosin which could result in a higher serum level.
Hydralazine Hydralazine The metabolism of Hydralazine can be decreased when combined with Cyclosporine.
Cimetidine Cimetidine The metabolism of Cyclosporine can be decreased when combined with Cimetidine.
Gentamicin Injection Gentamicin Injection Cyclosporine may decrease the excretion rate of Gentamicin which could result in a higher serum level.
Warfarin Warfarin The serum concentration of Warfarin can be increased when it is combined with Cyclosporine.
Clonazepam Clonazepam The therapeutic efficacy of Clonazepam can be decreased when used in combination with Cyclosporine.
Loperamide Loperamide The metabolism of Cyclosporine can be decreased when combined with Loperamide.
Promethazine Promethazine The metabolism of Cyclosporine can be decreased when combined with Promethazine.
Meclofenamate Meclofenamate The risk or severity of renal failure and hypertension can be increased when Meclofenamic acid is combined with Cyclosporine.
Daunorubicin Daunorubicin Daunorubicin may increase the immunosuppressive activities of Cyclosporine.
Nitrofurantoin Nitrofurantoin Cyclosporine may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
Griseofulvin Griseofulvin The serum concentration of Cyclosporine can be decreased when it is combined with Griseofulvin.
Digoxin Digoxin The serum concentration of Digoxin can be increased when it is combined with Cyclosporine.
Loxapine Loxapine The serum concentration of Cyclosporine can be increased when it is combined with Loxapine.
Chloroquine Chloroquine The serum concentration of Cyclosporine can be increased when it is combined with Chloroquine.
Quinine Quinine The metabolism of Cyclosporine can be decreased when combined with Quinine.
Ethosuximide Ethosuximide The therapeutic efficacy of Ethosuximide can be decreased when used in combination with Cyclosporine.
Calcitriol Calcitriol The metabolism of Cyclosporine can be increased when combined with Calcitriol.
Triamterene Triamterene The risk or severity of hyperkalemia can be increased when Triamterene is combined with Cyclosporine.
Sulfinpyrazone Sulfinpyrazone The serum concentration of Cyclosporine can be decreased when it is combined with Sulfinpyrazone.
Chlorothiazide Chlorothiazide The risk or severity of renal failure can be increased when Chlorothiazide is combined with Cyclosporine.
Chlorthalidone Chlorthalidone The risk or severity of renal failure can be increased when Chlorthalidone is combined with Cyclosporine.
Metolazone Metolazone The risk or severity of renal failure can be increased when Metolazone is combined with Cyclosporine.
Clindamycin Injection Clindamycin Injection The metabolism of Clindamycin can be decreased when combined with Cyclosporine.
Secobarbital Secobarbital The metabolism of Cyclosporine can be increased when combined with Secobarbital.
Desipramine Desipramine The metabolism of Desipramine can be decreased when combined with Cyclosporine.
Amitriptyline Amitriptyline The metabolism of Amitriptyline can be decreased when combined with Cyclosporine.
Imipramine Imipramine The metabolism of Imipramine can be decreased when combined with Cyclosporine.
Probenecid Probenecid The risk or severity of renal failure can be increased when Probenecid is combined with Cyclosporine.
Quinidine Quinidine The serum concentration of Quinidine can be increased when it is combined with Cyclosporine.
Procainamide Procainamide The metabolism of Procainamide can be decreased when combined with Cyclosporine.
Isoniazid Isoniazid The metabolism of Isoniazid can be decreased when combined with Cyclosporine.
Pyrazinamide Pyrazinamide The serum concentration of Cyclosporine can be decreased when it is combined with Pyrazinamide.
Rifampin Rifampin The metabolism of Cyclosporine can be increased when combined with Rifampicin.
Disopyramide Disopyramide Cyclosporine may decrease the excretion rate of Disopyramide which could result in a higher serum level.
Valproic Acid Valproic Acid The metabolism of Valproic acid can be decreased when combined with Cyclosporine.
Tamoxifen Tamoxifen The metabolism of Cyclosporine can be decreased when combined with Tamoxifen.
Mitomycin Mitomycin Mitomycin may increase the immunosuppressive activities of Cyclosporine.
Butabarbital Butabarbital The metabolism of Butabarbital can be increased when combined with Cyclosporine.
Levothyroxine Levothyroxine The serum concentration of Cyclosporine can be decreased when it is combined with Levothyroxine.
Liothyronine Liothyronine Cyclosporine may decrease the excretion rate of Liothyronine which could result in a higher serum level.
Methimazole Methimazole Methimazole may increase the immunosuppressive activities of Cyclosporine.
Propylthiouracil Propylthiouracil Propylthiouracil may increase the immunosuppressive activities of Cyclosporine.
Chlorpropamide Chlorpropamide Cyclosporine may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.
Tolbutamide Tolbutamide Cyclosporine may decrease the excretion rate of Tolbutamide which could result in a higher serum level.
Tolazamide Tolazamide Cyclosporine may decrease the excretion rate of Tolazamide which could result in a higher serum level.
Dextromethorphan Dextromethorphan The metabolism of Cyclosporine can be decreased when combined with Dextromethorphan.
Dinoprostone Dinoprostone The excretion of Dinoprostone can be decreased when combined with Cyclosporine.
Cyclobenzaprine Cyclobenzaprine Cyclosporine may increase the neurotoxic activities of Cyclobenzaprine.
Niacin Niacin The metabolism of Cyclosporine can be decreased when combined with Niacin.
Baclofen Baclofen Cyclosporine may decrease the excretion rate of Baclofen which could result in a higher serum level.
Chlorpheniramine Chlorpheniramine The metabolism of Cyclosporine can be decreased when combined with Chlorpheniramine.
Meclizine Meclizine The metabolism of Meclizine can be decreased when combined with Cyclosporine.
Ethambutol Ethambutol Cyclosporine may decrease the excretion rate of Ethambutol which could result in a higher serum level.
Methyclothiazide Methyclothiazide The risk or severity of renal failure can be increased when Methyclothiazide is combined with Cyclosporine.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of renal failure can be increased when Hydrochlorothiazide is combined with Cyclosporine.
Dantrolene Dantrolene The risk or severity of hyperkalemia can be increased when Cyclosporine is combined with Dantrolene.
Chlorzoxazone Chlorzoxazone The metabolism of Cyclosporine can be decreased when combined with Chlorzoxazone.
Pyridoxine Pyridoxine Cyclosporine may decrease the excretion rate of Pyridoxine which could result in a higher serum level.
Folic Acid Folic Acid Cyclosporine may decrease the excretion rate of Folic acid which could result in a higher serum level.
Danazol Danazol The risk or severity of liver damage can be increased when Danazol is combined with Cyclosporine.
Disulfiram Disulfiram The metabolism of Cyclosporine can be decreased when combined with Disulfiram.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The metabolism of Cyclosporine can be decreased when combined with Propranolol.
Minoxidil Minoxidil The risk or severity of Hypertrichosis can be increased when Cyclosporine is combined with Minoxidil.
Pseudoephedrine Pseudoephedrine The risk or severity of hypertension can be increased when Cyclosporine is combined with Pseudoephedrine.
Nortriptyline Nortriptyline The metabolism of Nortriptyline can be decreased when combined with Cyclosporine.
Spironolactone Spironolactone The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Cyclosporine.
Amphotericin B Injection Amphotericin B Injection Amphotericin B may increase the nephrotoxic activities of Cyclosporine.
Mercaptopurine Mercaptopurine Mercaptopurine may increase the immunosuppressive activities of Cyclosporine.
Phytonadione Phytonadione Cyclosporine may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Amikacin Injection Amikacin Injection Cyclosporine may decrease the excretion rate of Amikacin which could result in a higher serum level.
Nadolol Nadolol The metabolism of Nadolol can be decreased when combined with Cyclosporine.
Allopurinol Allopurinol The serum concentration of Cyclosporine can be increased when it is combined with Allopurinol.
Fluoxymesterone Fluoxymesterone The risk or severity of liver damage can be increased when Fluoxymesterone is combined with Cyclosporine.
Clomiphene Clomiphene The serum concentration of Cyclosporine can be increased when it is combined with Clomifene.
Flavoxate Flavoxate Cyclosporine may decrease the excretion rate of Flavoxate which could result in a higher serum level.
Fluorouracil Injection Fluorouracil Injection Fluorouracil may increase the immunosuppressive activities of Cyclosporine.
Colchicine Colchicine Colchicine may increase the immunosuppressive activities of Cyclosporine.
Cefaclor Cefaclor Cyclosporine may decrease the excretion rate of Cefaclor which could result in a higher serum level.
Cefadroxil Cefadroxil Cyclosporine may decrease the excretion rate of Cefadroxil which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Cefazolin.
Cephalexin Cephalexin The metabolism of Cyclosporine can be decreased when combined with Cephalexin.
Cefoxitin Injection Cefoxitin Injection The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Cefoxitin.
Dacarbazine Dacarbazine Dacarbazine may increase the immunosuppressive activities of Cyclosporine.
Acetazolamide Acetazolamide The serum concentration of Cyclosporine can be increased when it is combined with Acetazolamide.
Nystatin Nystatin The serum concentration of Cyclosporine can be increased when it is combined with Nystatin.
Cefotaxime Injection Cefotaxime Injection The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Cefotaxime.
Calcitonin Salmon Injection Calcitonin Salmon Injection Cyclosporine may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
Bacillus Calmette-Guerin (BCG) Vaccine Bacillus Calmette-Guerin (BCG) Vaccine The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Cyclosporine.
Ketoconazole Ketoconazole Ketoconazole may increase the nephrotoxic activities of Cyclosporine.
Pyrantel Pyrantel The therapeutic efficacy of Pyrantel can be increased when used in combination with Cyclosporine.
Thiotepa Injection Thiotepa Injection Thiotepa may increase the immunosuppressive activities of Cyclosporine.
Vincristine Injection Vincristine Injection Vincristine may increase the immunosuppressive activities of Cyclosporine.
Captopril Captopril The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cyclosporine is combined with Captopril.
Dipyridamole Dipyridamole Cyclosporine may decrease the excretion rate of Dipyridamole which could result in a higher serum level.
Isoxsuprine Isoxsuprine The risk or severity of hypertension can be increased when Cyclosporine is combined with Isoxsuprine.
Vinblastine Vinblastine Vinblastine may increase the immunosuppressive activities of Cyclosporine.
Ethacrynic Acid Ethacrynic Acid The risk or severity of adverse effects can be increased when Cyclosporine is combined with Etacrynic acid.
Colistimethate Injection Colistimethate Injection The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Colistimethate.
Metoprolol Metoprolol The metabolism of Cyclosporine can be decreased when combined with Metoprolol.
Hydroxyzine Hydroxyzine The metabolism of Hydroxyzine can be decreased when combined with Cyclosporine.
Thiothixene Thiothixene Cyclosporine may increase the neurotoxic activities of Thiothixene.
Aspirin Aspirin The risk or severity of renal failure and hypertension can be increased when Acetylsalicylic acid is combined with Cyclosporine.
Salsalate Salsalate The risk or severity of renal failure and hypertension can be increased when Salsalate is combined with Cyclosporine.
Chlorambucil Chlorambucil Chlorambucil may increase the immunosuppressive activities of Cyclosporine.
Alprazolam Alprazolam The metabolism of Alprazolam can be decreased when combined with Cyclosporine.
Temazepam Temazepam Cyclosporine may decrease the excretion rate of Temazepam which could result in a higher serum level.
Triazolam Triazolam The metabolism of Triazolam can be decreased when combined with Cyclosporine.
Dicyclomine Dicyclomine Cyclosporine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Propantheline Propantheline Cyclosporine may decrease the excretion rate of Propantheline which could result in a higher serum level.
Trimethoprim Trimethoprim Cyclosporine may decrease the excretion rate of Trimethoprim which could result in a higher serum level.
Diltiazem Diltiazem The metabolism of Cyclosporine can be decreased when combined with Diltiazem.
Nifedipine Nifedipine The metabolism of Cyclosporine can be decreased when combined with Nifedipine.
Timolol Timolol The metabolism of Timolol can be decreased when combined with Cyclosporine.
Verapamil Verapamil The serum concentration of Cyclosporine can be increased when it is combined with Verapamil.
Atenolol Atenolol The metabolism of Atenolol can be decreased when combined with Cyclosporine.
Pindolol Pindolol The metabolism of Pindolol can be decreased when combined with Cyclosporine.
Cisplatin Injection Cisplatin Injection Cisplatin may increase the immunosuppressive activities of Cyclosporine.
Diflunisal Diflunisal The risk or severity of renal failure and hypertension can be increased when Diflunisal is combined with Cyclosporine.
Piroxicam Piroxicam The risk or severity of renal failure and hypertension can be increased when Piroxicam is combined with Cyclosporine.
Bumetanide Bumetanide The risk or severity of renal failure can be increased when Cyclosporine is combined with Bumetanide.
Streptozocin Streptozocin Streptozocin may increase the immunosuppressive activities of Cyclosporine.
Etoposide Etoposide The serum concentration of Etoposide can be increased when it is combined with Cyclosporine.
Glyburide Glyburide The therapeutic efficacy of Glyburide can be decreased when used in combination with Cyclosporine.
Glipizide Glipizide Cyclosporine may decrease the excretion rate of Glipizide which could result in a higher serum level.
Indapamide Indapamide The risk or severity of renal failure can be increased when Indapamide is combined with Cyclosporine.
Amoxicillin Amoxicillin Cyclosporine may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
Dicloxacillin Dicloxacillin The metabolism of Cyclosporine can be increased when combined with Dicloxacillin.
Nafcillin Injection Nafcillin Injection The metabolism of Cyclosporine can be increased when combined with Nafcillin.
Oxacillin Injection Oxacillin Injection Cyclosporine may decrease the excretion rate of Oxacillin which could result in a higher serum level.
Pentoxifylline Pentoxifylline Cyclosporine may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.
Pentamidine Injection Pentamidine Injection The metabolism of Cyclosporine can be decreased when combined with Pentamidine.
Ceftriaxone Injection Ceftriaxone Injection Cyclosporine may decrease the excretion rate of Ceftriaxone which could result in a higher serum level.
Labetalol Labetalol The metabolism of Labetalol can be decreased when combined with Cyclosporine.
Auranofin Auranofin Cyclosporine may decrease the excretion rate of Auranofin which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection Cyclosporine may decrease the excretion rate of Leuprolide which could result in a higher serum level.
Gemfibrozil Gemfibrozil The risk or severity of renal failure can be increased when Cyclosporine is combined with Gemfibrozil.
Guanabenz Guanabenz The risk or severity of hypertension can be increased when Cyclosporine is combined with Guanabenz.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Adefovir dipivoxil.
Ceftazidime Injection Ceftazidime Injection Cyclosporine may decrease the excretion rate of Ceftazidime which could result in a higher serum level.
Ketoprofen Ketoprofen The risk or severity of renal failure and hypertension can be increased when Ketoprofen is combined with Cyclosporine.
Cefotetan Injection Cefotetan Injection Cyclosporine may decrease the excretion rate of Cefotetan which could result in a higher serum level.
Pimozide Pimozide The metabolism of Cyclosporine can be decreased when combined with Pimozide.
Enalapril Enalapril The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cyclosporine is combined with Enalapril.
Flurbiprofen Flurbiprofen The risk or severity of renal failure and hypertension can be increased when Flurbiprofen is combined with Cyclosporine.
Amiodarone Amiodarone The serum concentration of Cyclosporine can be increased when it is combined with Amiodarone.
Aztreonam Injection Aztreonam Injection Cyclosporine may decrease the excretion rate of Aztreonam which could result in a higher serum level.
Buspirone Buspirone The metabolism of Cyclosporine can be decreased when combined with Buspirone.
Lovastatin Lovastatin The serum concentration of Lovastatin can be increased when it is combined with Cyclosporine.
Ciprofloxacin Ciprofloxacin Cyclosporine may increase the nephrotoxic activities of Ciprofloxacin.
Mesalamine Mesalamine The risk or severity of renal failure and hypertension can be increased when Mesalazine is combined with Cyclosporine.
Diclofenac Diclofenac The serum concentration of Diclofenac can be increased when it is combined with Cyclosporine.
Fluoxetine Fluoxetine The metabolism of Cyclosporine can be decreased when combined with Fluoxetine.
Nimodipine Nimodipine Cyclosporine may decrease the antihypertensive activities of Nimodipine.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection Interferon alfa-2b may increase the immunosuppressive activities of Cyclosporine.
Clozapine Clozapine The metabolism of Cyclosporine can be decreased when combined with Clozapine.
Estazolam Estazolam Cyclosporine may decrease the excretion rate of Estazolam which could result in a higher serum level.
Idarubicin Idarubicin Idarubicin may increase the immunosuppressive activities of Cyclosporine.
Ofloxacin Ofloxacin The risk or severity of nephrotoxicity can be increased when Ofloxacin is combined with Cyclosporine.
Didanosine Didanosine Cyclosporine may decrease the excretion rate of Didanosine which could result in a higher serum level.
Fludarabine Injection Fludarabine Injection Fludarabine may increase the immunosuppressive activities of Cyclosporine.
Pentostatin Injection Pentostatin Injection Pentostatin may increase the immunosuppressive activities of Cyclosporine.
Clarithromycin Clarithromycin The metabolism of Cyclosporine can be decreased when combined with Clarithromycin.
Benazepril Benazepril The risk or severity of hyperkalemia can be increased when Cyclosporine is combined with Benazepril.
Etodolac Etodolac The risk or severity of renal failure and hypertension can be increased when Etodolac is combined with Cyclosporine.
Felodipine Felodipine The metabolism of Cyclosporine can be decreased when combined with Felodipine.
Fosinopril Fosinopril Cyclosporine may decrease the excretion rate of Fosinopril which could result in a higher serum level.
Nabumetone Nabumetone The risk or severity of renal failure and hypertension can be increased when Nabumetone is combined with Cyclosporine.
Pravastatin Pravastatin The serum concentration of Pravastatin can be increased when it is combined with Cyclosporine.
Quinapril Quinapril The risk or severity of hyperkalemia can be increased when Cyclosporine is combined with Quinapril.
Ramipril Ramipril The risk or severity of hyperkalemia can be increased when Cyclosporine is combined with Ramipril.
Simvastatin Simvastatin The serum concentration of Simvastatin can be increased when it is combined with Cyclosporine.
Amlodipine Amlodipine Cyclosporine may decrease the antihypertensive activities of Amlodipine.
Teniposide Injection Teniposide Injection Teniposide may increase the immunosuppressive activities of Cyclosporine.
Itraconazole Itraconazole The serum concentration of Cyclosporine can be increased when it is combined with Itraconazole.
Lisinopril Lisinopril Cyclosporine may decrease the excretion rate of Lisinopril which could result in a higher serum level.
Oxaprozin Oxaprozin The risk or severity of renal failure and hypertension can be increased when Oxaprozin is combined with Cyclosporine.
Rifabutin Rifabutin The metabolism of Cyclosporine can be increased when combined with Rifabutin.
Sotalol Sotalol The metabolism of Sotalol can be decreased when combined with Cyclosporine.
Bisoprolol Bisoprolol The serum concentration of Bisoprolol can be increased when it is combined with Cyclosporine.
Zolpidem Zolpidem The metabolism of Zolpidem can be decreased when combined with Cyclosporine.
Doxazosin Doxazosin The metabolism of Cyclosporine can be decreased when combined with Doxazosin.
Terazosin Terazosin Cyclosporine may decrease the antihypertensive activities of Terazosin.
Isradipine Isradipine The metabolism of Cyclosporine can be decreased when combined with Isradipine.
Omeprazole Omeprazole The serum concentration of Cyclosporine can be increased when it is combined with Omeprazole.
Cisapride Cisapride The metabolism of Cisapride can be decreased when combined with Cyclosporine.
Gabapentin Gabapentin The therapeutic efficacy of Gabapentin can be decreased when used in combination with Cyclosporine.
Fluvastatin Fluvastatin The serum concentration of Fluvastatin can be increased when it is combined with Cyclosporine.
Venlafaxine Venlafaxine The metabolism of Cyclosporine can be decreased when combined with Venlafaxine.
Nizatidine Nizatidine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cyclosporine is combined with Nizatidine.
Stavudine Stavudine The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cyclosporine is combined with Stavudine.
Famciclovir Famciclovir The metabolism of Cyclosporine can be decreased when combined with Famciclovir.
Fluvoxamine Fluvoxamine The metabolism of Cyclosporine can be decreased when combined with Fluvoxamine.
Nefazodone Nefazodone The metabolism of Cyclosporine can be decreased when combined with Nefazodone.
Lamotrigine Lamotrigine Cyclosporine may decrease the excretion rate of Lamotrigine which could result in a higher serum level.
Losartan Losartan The risk or severity of hyperkalemia can be increased when Losartan is combined with Cyclosporine.
Valacyclovir Valacyclovir Cyclosporine may decrease the excretion rate of Valaciclovir which could result in a higher serum level.
Tramadol Tramadol The metabolism of Cyclosporine can be decreased when combined with Tramadol.
Vinorelbine Injection Vinorelbine Injection Vinorelbine may increase the immunosuppressive activities of Cyclosporine.
Carboplatin Injection Carboplatin Injection Carboplatin may increase the immunosuppressive activities of Cyclosporine.
Moexipril Moexipril The risk or severity of hyperkalemia can be increased when Cyclosporine is combined with Moexipril.
Lansoprazole Lansoprazole The metabolism of Cyclosporine can be increased when combined with Lansoprazole.
Alprostadil Urogenital Alprostadil Urogenital The excretion of Alprostadil can be decreased when combined with Cyclosporine.
Ifosfamide Injection Ifosfamide Injection Ifosfamide may increase the immunosuppressive activities of Cyclosporine.
Pegaspargase Injection Pegaspargase Injection Pegaspargase may increase the immunosuppressive activities of Cyclosporine.
Nicardipine Nicardipine The metabolism of Cyclosporine can be decreased when combined with Nicardipine.
Bupropion Bupropion The risk or severity of seizure can be increased when Cyclosporine is combined with Bupropion.
Ticlopidine Ticlopidine The metabolism of Cyclosporine can be decreased when combined with Ticlopidine.
Saquinavir Saquinavir The metabolism of Saquinavir can be decreased when combined with Cyclosporine.
Metformin Metformin Cyclosporine may decrease the excretion rate of Metformin which could result in a higher serum level.
Dalteparin Injection Dalteparin Injection The risk or severity of hyperkalemia can be increased when Cyclosporine is combined with Dalteparin.
Nisoldipine Nisoldipine The metabolism of Cyclosporine can be decreased when combined with Nisoldipine.
Lamivudine Lamivudine Cyclosporine may decrease the excretion rate of Lamivudine which could result in a higher serum level.
Riluzole Riluzole Cyclosporine may decrease the excretion rate of Riluzole which could result in a higher serum level.
Acarbose Acarbose Cyclosporine may decrease the excretion rate of Acarbose which could result in a higher serum level.
Glimepiride Glimepiride Cyclosporine may decrease the excretion rate of Glimepiride which could result in a higher serum level.
Gemcitabine Injection Gemcitabine Injection Gemcitabine may increase the immunosuppressive activities of Cyclosporine.
Indinavir Indinavir The metabolism of Cyclosporine can be decreased when combined with Indinavir.
Ritonavir Ritonavir The serum concentration of Cyclosporine can be increased when it is combined with Ritonavir.
Docetaxel Injection Docetaxel Injection Docetaxel may increase the immunosuppressive activities of Cyclosporine.
Cidofovir Injection Cidofovir Injection Cyclosporine may decrease the excretion rate of Cidofovir which could result in a higher serum level.
Meropenem Injection Meropenem Injection Cyclosporine may decrease the excretion rate of Meropenem which could result in a higher serum level.
Clomipramine Clomipramine The metabolism of Clomipramine can be decreased when combined with Cyclosporine.
Zafirlukast Zafirlukast The metabolism of Zafirlukast can be decreased when combined with Cyclosporine.
Fosfomycin Fosfomycin Cyclosporine may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
Mirtazapine Mirtazapine The metabolism of Cyclosporine can be decreased when combined with Mirtazapine.
Trandolapril Trandolapril The risk or severity of hyperkalemia can be increased when Cyclosporine is combined with Trandolapril.
Topiramate Topiramate The metabolism of Cyclosporine can be increased when combined with Topiramate.
Valsartan Valsartan The risk or severity of hyperkalemia can be increased when Valsartan is combined with Cyclosporine.
Pramipexole Pramipexole Cyclosporine may decrease the excretion rate of Pramipexole which could result in a higher serum level.
Donepezil Donepezil The metabolism of Cyclosporine can be decreased when combined with Donepezil.
Nelfinavir Nelfinavir The metabolism of Cyclosporine can be decreased when combined with Nelfinavir.
Fexofenadine Fexofenadine The serum concentration of Cyclosporine can be increased when it is combined with Fexofenadine.
Azithromycin Azithromycin The metabolism of Cyclosporine can be decreased when combined with Azithromycin.
Loratadine Loratadine Cyclosporine may decrease the excretion rate of Loratadine which could result in a higher serum level.
Carvedilol Carvedilol The serum concentration of Cyclosporine can be increased when it is combined with Carvedilol.
Nilutamide Nilutamide Cyclosporine may decrease the excretion rate of Nilutamide which could result in a higher serum level.
Flutamide Flutamide The metabolism of Cyclosporine can be decreased when combined with Flutamide.
Selegiline Selegiline The metabolism of Cyclosporine can be decreased when combined with Selegiline.
Bicalutamide Bicalutamide The metabolism of Cyclosporine can be decreased when combined with Bicalutamide.
Sertraline Sertraline The metabolism of Cyclosporine can be decreased when combined with Sertraline.
Propafenone Propafenone The metabolism of Cyclosporine can be decreased when combined with Propafenone.
Letrozole Letrozole The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cyclosporine is combined with Letrozole.
Raloxifene Raloxifene The metabolism of Raloxifene can be decreased when combined with Cyclosporine.
Irbesartan Irbesartan The risk or severity of hyperkalemia can be increased when Irbesartan is combined with Cyclosporine.
Tamsulosin Tamsulosin The risk or severity of renal failure can be increased when Tamsulosin is combined with Cyclosporine.
Finasteride Finasteride The metabolism of Cyclosporine can be decreased when combined with Finasteride.
Quetiapine Quetiapine The metabolism of Quetiapine can be decreased when combined with Cyclosporine.
Cefepime Injection Cefepime Injection The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Cefepime.
Cefprozil Cefprozil The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Cefprozil.
Cefpodoxime Cefpodoxime The risk or severity of nephrotoxicity can be increased when Cyclosporine is combined with Cefpodoxime.
Cetirizine Cetirizine Cyclosporine may decrease the excretion rate of Cetirizine which could result in a higher serum level.
Paroxetine Paroxetine The metabolism of Cyclosporine can be decreased when combined with Paroxetine.
Tolcapone Tolcapone Cyclosporine may decrease the excretion rate of Tolcapone which could result in a higher serum level.
Citalopram Citalopram The metabolism of Citalopram can be decreased when combined with Cyclosporine.
Capecitabine Capecitabine Capecitabine may increase the immunosuppressive activities of Cyclosporine.
Efavirenz Efavirenz The serum concentration of Cyclosporine can be decreased when it is combined with Efavirenz.
Abacavir Abacavir Cyclosporine may decrease the excretion rate of Abacavir which could result in a higher serum level.
Sildenafil Sildenafil The metabolism of Sildenafil can be decreased when combined with Cyclosporine.
Trastuzumab Injection Trastuzumab Injection Trastuzumab may increase the immunosuppressive activities of Cyclosporine.
Celecoxib Celecoxib The risk or severity of renal failure and hypertension can be increased when Celecoxib is combined with Cyclosporine.
Rosiglitazone Rosiglitazone Cyclosporine may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.
Tolterodine Tolterodine The metabolism of Cyclosporine can be decreased when combined with Tolterodine.
Thalidomide Thalidomide Thalidomide may increase the immunosuppressive activities of Cyclosporine.
Oseltamivir Oseltamivir Cyclosporine may decrease the excretion rate of Oseltamivir which could result in a higher serum level.
Colesevelam Colesevelam The serum concentration of Cyclosporine can be decreased when it is combined with Colesevelam.
Balsalazide Balsalazide The risk or severity of renal failure and hypertension can be increased when Balsalazide is combined with Cyclosporine.
Nateglinide Nateglinide The metabolism of Cyclosporine can be decreased when combined with Nateglinide.
Galantamine Galantamine The metabolism of Cyclosporine can be decreased when combined with Galantamine.
Levetiracetam Levetiracetam The therapeutic efficacy of Levetiracetam can be decreased when used in combination with Cyclosporine.
Rabeprazole Rabeprazole The metabolism of Cyclosporine can be decreased when combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Cyclosporine can be increased when combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists

Still Confused? Ask the pharmacist a question here!